How anaprazole sodium works in people with liver or kidney problems
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the body absorbs and processes a drug called anaprazole sodium, which is used for stomach acid problems. It compares healthy people with those who have liver or kidney issues, and with older adults, to see if the drug needs different dosing for these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 70 years old (or 65 or older if you are in the older group).
- Your body mass index (BMI) must be between 18 and 32.
- You must be in one of these groups: generally healthy, have moderate liver problems (Child-Pugh B), have moderate to severe kidney problems (stages 3 or 4), or be 65 or older.
- You must not be allergic to the study drug or its ingredients.
- You must not have certain heart or stomach problems, and you must not have had major surgery or a severe infection in the past month.
- You must agree to use effective birth control during the study and for 6 months after the last dose (if you or your partner can become pregnant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called GS1-144 in women with mild or moderate liver problems and healthy women to see how the body handles the drug. It helps researchers understand if liver function affects the drug's safety and how it is processed.
This study checks how the body processes two medications when taken together: rifampin (an antibiotic) and anaprazole sodium (a stomach acid reducer). It is not a treatment trial — it is for healthy volunteers to see if these drugs interact in a way that could affect dosing.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This trial tests how a new drug called ABSK-011 is absorbed by the body when taken with a low-fat meal, a high-fat meal, or a stomach acid medicine. Healthy volunteers are needed to help understand these effects.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
This study tests a new drug called linaprazan glurate in healthy adults aged 18 to 65. It looks at how the drug moves through your body and if it affects your heart rhythm.
Hear when a new Hepatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.